The Dangers of Buying Soma (Carisoprodol) Online Without a Prescription: A 2025 Research Report
This report aggregates and analyzes 2025 Drug Enforcement Administration (DEA) forensic data on counterfeit carisoprodol (Soma) tablets purchased through illicit online channels. Key findings include: Contamination rates: 27% of seized samples contained xylazine (a veterinary tranquilizer), while 25% tested positive for fentanyl (DEA, 2025). Case study: Toxicological analysis of a patient who ingested counterfeit Soma revealed life-threatening adulterants (methamphetamine, supra-therapeutic carisoprodol doses). Regulatory context: Discussion of U.S. Schedule IV classification and legal consequences of non-prescription purchases. The study highlights the dangers of unregulated online pharmacies and provides evidence-based recommendations for safer alternatives, including: Telemedicine consultations for legitimate prescriptions FDA-approved pharmacy verification tools Data Sources: DEA forensic lab reports (March 2025) FDA counterfeit drug databases Peer-reviewed literature on prescription drug abuse (JAMA, 2025) Intended Audience: Healthcare professionals Policy makers Medication safety researchers License:Creative Commons Attribution 4.0 International (CC-BY 4.0)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-04-03
- DOI
- https://doi.org/10.5281/zenodo.15131375
- Primary Topic
- Pharmaceutical Quality and Counterfeiting
- Type
- article
- Field-Weighted Citation Impact
- 0.00